Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XTANDI for Bone cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where XTANDI was used for Bone cancer.

Most Reported Side Effects for XTANDI

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 235 16.9% 110 34
Death 234 16.8% 234 13
Fatigue 162 11.6% 19 18
Drug ineffective 158 11.3% 7 11
Prostatic specific antigen increased 94 6.8% 5 7
Nausea 69 5.0% 5 13
Asthenia 62 4.5% 5 13
Decreased appetite 56 4.0% 12 8
Dizziness 52 3.7% 2 6
Diarrhoea 51 3.7% 3 12
Back pain 41 2.9% 6 10
Malaise 41 2.9% 4 9
Arthralgia 36 2.6% 5 5
Investigation 31 2.2% 6 31
Dyspnoea 30 2.2% 2 13

Other Indications for XTANDI

Prostate cancer (787) Product used for unknown indication (384) Prostate cancer metastatic (135) Neoplasm malignant (23) Hormone-refractory prostate cancer (8) Neoplasm prostate (6) Ill-defined disorder (5)

Other Drugs Used for Bone cancer

PALBOCICLIB (493) LENALIDOMIDE (342) CABOZANTINIB S-MALATE (328) DENOSUMAB (219) ENZALUTAMIDE (213) PAZOPANIB (182) ERLOTINIB (174) CAPECITABINE (143) BEVACIZUMAB (140) POMALIDOMIDE (114)

Related Pages

XTANDI Full Profile All Bone cancer Drugs XTANDI Demographics XTANDI Timeline